Vulnerabilities

Search by TI id or any alias (CVE, GHSA), vendor, product or CWE.

Filters

Reset all

Threatist priority CRITICAL 0 HIGH 0 MEDIUM 1 LOW 0

Signals Exploited in the wild (KEV) 0 Patch available 0 No fix listed 1 Has CVE 1

Fix status Fixed 0 Partial 0 Will not fix 0 Deferred 0 No fix listed 1

Impact type Code execution 0 Privilege escalation 0 Security bypass 0 Information disclosure 0 Tampering 0 Denial of service 0 Spoofing 0 Cross-site scripting 1 SQL injection 0

Attack vector Network 1 Adjacent network 0 Local 0 Physical 0

Product

Products as named in CPE, with their records.

Published Last 7 days Last 30 days Last 12 months Any time

Weakness (CWE) CWE-79 Improper Neutralization of Input During Web Page Generation 1

1 selected

1 record

Sort

Vendor: Deathbreak × Clear all filters

TI-2024-30011 CVE-2024-44837 · GHSA-vxpg-8v7f-78w3

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug…

Priority MEDIUM 58

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.

CVSS 3.1MEDIUM 5.4· Network · Low privileges · User interaction · EPSS 0.00311 · Published 2024-09-06 · No fix listed CWE-79

THREATIST.IO

Vulnerability intelligence for security teams and AI agents.

Vulnerabilities Vendors Exploited (KEV) API & MCP Newsletter Privacy policy Terms of use

Newsletter Vulnerability intelligence in your inbox Subscribe

© 2026 Threatist.ioData: CVE Program, NVD, CISA KEV, FIRST EPSS, GitHub Advisory Database and Red Hat security data (both CC BY 4.0), Microsoft Security Response Center. This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences

We would like to use Google Analytics cookies to see how the site is used. They are set only if you accept. Privacy policy